Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy
Clinical trial NCT01922921 · COMPLETED
Trial details
- NCT number
- NCT01922921
- Sponsor
- University of Washington
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-05
- Primary completion
- 2019-10-31
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.